KATHERINE JANEZIC: Open Payments
NPI 1114551983 · NILES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,447 in 111 payments from 24 companies in 2025. Trend: 2023 $3,026 · 2024 $3,002 · 2025 $2,447
Food & beverage: $2,343Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $601 |
| Janssen Biotech, Inc. | 17 | $552 |
| Galderma Laboratories, L.P. | 17 | $214 |
| Regeneron Healthcare Solutions, Inc. | 7 | $141 |
| GENZYME CORPORATION | 4 | $112 |
| Lilly USA, LLC | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 3 | $89 |
| PFIZER INC. | 3 | $77 |
| Incyte Corporation | 3 | $73 |
| UCB, Inc. | 2 | $66 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, NEMLUVIO, RINVOQ, CIBINQO, EBGLYSS, OPZELURA.
Industry payments across IL — which companies pay providers there.
